News from cantargia ab
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
26 May, 2022, 22:32 BST Cantargia presents clinical interim results at ASCO 2022 highlighting the potential of nadunolimab in combination with checkpoint inhibitor
Cantargia (Cantargia AB) (NASDAQ Stockholm: CANTA) today reported new results from the phase Ib clinical trial CIRIFOUR in 15 solid tumor patients,...
01 Mar, 2022, 10:20 GMT Cantargia reports positive preclinical efficacy data for CAN10 demonstrating anti-fibrotic and anti-inflammatory effects in systemic sclerosis
Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced new preclinical data on its anti-inflammatory IL1RAP-binding antibody CAN10 showing ...